Blauvelt, Andrew
Shi, Nianwen
Burge, Russel
Atiya, Bilal
Zhu, Baojin
Somani, Najwa
Ridenour, Terri
Lew, Carolyn R.
Zimmerman, Nicole M.
Murage, Mwangi J.
Article History
Accepted: 8 August 2022
First Online: 26 September 2022
Declarations
:
: The study was funded by Eli Lilly and Company. IBM Watson Health received funding for this study from Eli Lilly and Company. Independent analyses were conducted by IBM Watson Health. Eli Lilly and Company and IBM Watson Health collaborated on designing the study and interpreting results.
: Andrew Blauvelt has served as a scientific adviser/received honoraria from AbbVie, Abcentra, Aligos, Almirall, Amgen, Arcutis, Arena, Aslan, Athenex, Boehringer Ingelheim, Bristol-Myers Squibb, Dermavant, EcoR1, Eli Lilly and Company, Evommune, Forte, Galderma, Incyte, Janssen, Landos, Leo, Novartis, Pfizer, Rapt, Regeneron, Sanofi Genzyme, Sun Pharma, UCB Pharma, and Vibliome; has acted as a clinical study investigator/institution has received clinical study funds from AbbVie, Amgen, Arcutis, Athenex, Boehringer Ingelheim, Bristol-Myers Squibb, Dermavant, Eli Lilly and Company, Galderma, Incyte, Janssen, Leo, Novartis, Pfizer, Regeneron, Sun Pharma, and UCB Pharma. Nianwen Shi, Carolyn R. Lew, and Nicole M. Zimmerman are employees of IBM Watson Health, which was compensated by Eli Lilly and Company for conducting this research. Russel Burge, Bilal Atiya, Baojin Zhu, Najwa Somani, Terri Ridenour, and Mwangi Murage are full-time employees and/or minor stockholders of Eli Lilly and Company.
: The datasets and codes used for the analyses in the current study are not publicly available due to proprietary reasons. However, IBM MarketScan<sup>®</sup> Research Databases from IBM Watson Health, USA, are available with a licensing fee.
: Nianwen Shi, Russel Burge, Terri Ridenour, and Mwangi Murage contributed to the study conception or design. All authors contributed to acquisition, analysis, or interpretation of data. All authors critically revised the manuscript for important intellectual content. All authors provided final approval of the version to be published and agree to be accountable for all aspects of the work.
: All database records used in the study are de-identified and fully compliant with the US Health Insurance Portability and Accountability Act of 1996. This study was exempted from Institutional Review Board approval as it did not involve collection, use, or transmittal of individually identifiable data.
: Not applicable.
: Not applicable.